Health5 Nov
After Ozempic: the next obesity drugs aim for more weight loss, less muscle loss
A review in Science looks at the next wave of obesity drugs. Generic semaglutide is already sold in India, but patents may delay it in Spain until 2031.
A review in Science looks at the next wave of obesity drugs. Generic semaglutide is already sold in India, but patents may delay it in Spain until 2031.
More than 373,000 people were diagnosed with cancer in England in 2024, a record. Yet the NHS is still missing its targets for diagnosing and treating patients on time.
A British doctor who tested positive for Ebola in DR Congo has landed in the UK and is now in a specialist isolation unit in London. Officials say public risk is low.